Novartis's cancer therapy wins UK backing after initial lymphoma snub

Novartis's Kymriah cell therapy won the blessing of health authorities in England for adult lymphoma patients, the Swiss drugmaker said on Friday, reversing last year's rejection.

from Reuters: Health News https://reut.rs/2TtqcDK
via IFTTT